- Poster presentation
- Open Access
An automatic method for myocardial T2* curve fitting in thalassemia patients with severe iron overload
© Meloni et al; licensee BioMed Central Ltd. 2013
- Published: 30 January 2013
- Iron Overload
- Thalassemia Patient
- Thalassemia Major
- Myocardial Iron
- Cardiac Iron
Myocardial iron overload assessment by multislice multiecho T2* technique is used in the clinical management of thalassemia major (TM) patients. Signal decay curves are extracted from the 16 left ventricular (LV) segments and the fitting of these curves to a mono-exponential model provides the corresponding T2* values. In patients with severe cardiac iron overload, where signal will decay quickly becoming comparable to image noise, manual truncation of signal decay curves excluding later echo times (TEs) is adopted. In this study an automatic truncation method avoiding the variability associated with the manual selection of the truncation point is introduced and validated.
Twenty patients (13 males, age 33±7 years) enrolled in the MIOT Network and diagnosed for severe iron overload (T2*<10 ms) were considered. Using a previously validated software the segmental T2* values were evaluated by the standard methodology (i.e. manual truncation).
Images were independently analysed by the developed automated approach. The percentage fitting error (e) was computed as the root mean square error (MRSE) between the signal decay curve and the mono-exponential model normalized to the mean value of the signal. If e was > 5%, the algorithm cut-off the last TE and performed again the fitting. The procedure was iterated until the error become <5% or the number of TEs become equal to three. To assess the inter-operator variability, the dataset was processed by a second operator.
Truncation of signal decay curve needed to compensate for low signal in later echoes in patients with severe iron overload can be effectively automatized avoiding operator induced variability.
The MIOT project receives "no-profit support" from industrial sponsorships (Chiesi and Apotex). This study was also supported by: "Ministero della Salute, fondi ex art. 12 D.Lgs. 502/92 e s.m.i., ricerca sanitaria finalizzata anno 2006" e "Fondazione L. Giambrone".
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.